Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter

Mol Ther. 2021 Apr 7;29(4):1363-1365. doi: 10.1016/j.ymthe.2021.03.001. Epub 2021 Mar 10.

Authors

Bart De Geest¹, Mudit Mishra²

Affiliations

¹ Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, Leuven, Belgium. Electronic address: bart.degeest@kuleuven.be.
² Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: drmuditm@gmail.com.

No abstract available

Publication types

Comment

MeSH terms

Cardiomyopathies* / chemically induced
Cardiomyopathies* / genetics
Cardiotoxicity / etiology
Doxorubicin / adverse effects
Heart
Humans
Telomerase*

Substances

Doxorubicin
TERT protein, human
Telomerase